Are Cure Claims for CAR T-Cell Therapy Premature?

The top news to come out of the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO), which concluded on Tuesday, focused on claims that immune cellular therapy with CAR T-cells provides a potentially curative approach for myeloma. It is way too soon, in my opinion, for such suggestions, both in terms of treatment benefit and toxicities and/or side effects.

Pages